Vantage Consulting Group Inc Diversified Active

CIK: 0001843547 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 12, 2025

Total Value ($000): $10,492 (100.0% shares, 0.0% debt)

Holdings (5)

BW Babcock & Wilcox Enterprises Inc. 37.8%

Value ($000) $3,963 Shares 2,416,200 Est. Cost $5.86 Unrealized -63.9%

CBUS Cibus, Inc. 30.3%

Value ($000) $3,180 Shares 1,143,949 Est. Cost $17.98 Unrealized -78.5%

ADCT ADC Therapeutics SA 16.1%

Value ($000) $1,693 Shares 850,737 Est. Cost $32.77 Unrealized -92.0%

— Potbelly Corporation 14.8%

Value ($000) $1,553 Shares 164,875 Est. Cost $9.42 Unrealized —

— Fibrogen, Inc 1.0%

Value ($000) $104 Shares 195,707 Est. Cost $37.09 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BW	Babcock & Wilcox Enterprises Inc.	2,416,200	$3,963	37.8%	$5.86	-63.9%	COM	05614L209
CBUS	Cibus, Inc.	1,143,949	$3,180	30.3%	$17.98	-78.5%	Com	17166A101
ADCT	ADC Therapeutics SA	850,737	$1,693	16.1%	$32.77	-92.0%	Com	H0036K147
—	Potbelly Corporation	164,875	$1,553	14.8%	$9.42	—	COM	73754Y100
—	Fibrogen, Inc	195,707	$104	1.0%	$37.09	—	Com	31572Q808